title: SGLT2 inhibitors for diabetes: turning symptoms into therapy.
authors.affiliation: Diabetes Centre, VU University Medical Centre, Amsterdam, 1018 HZ, Netherlands. m.diamant@vumc.nl
authors.forename: Michaela
authors.initials: M
authors.lastname: Diamant
authors.forename: Linde M
authors.initials: LM
authors.lastname: Morsink
mesh_terms: D000068896:Canagliflozin; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005960:Glucosides / Q000008:administration & dosage*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage*
chemical_list: D005960:Glucosides; D007004:Hypoglycemic Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D013453:Sulfonylurea Compounds; D013876:Thiophenes; D000068896:Canagliflozin; C057619:glimepiride